Novartis AG's growth products as percent of pharma revenue 2009-2016

This statistic depicts the contribution of growth products to the pharmaceutical revenue of multinational pharmaceutical company Novartis from 2009 to 2016. Novartis AG is one of the largest pharmaceutical companies and is based in Basel, Switzerland. In 2009, Novartis generated a pharmaceutical revenue of some 28.3 billion U.S. dollars. Some 14 percent of this amount were generated by growth products.

Contribution of Novartis AG's growth products to pharmaceutical revenue from 2009 to 2016*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Release date

January 2017



Survey time period

2009 to 2016

Supplementary notes

* Novartis Pharmaceuticals division. Growth products are defined as products launched since 2009 or later, or with exclusivity until at least the next four years in key markets (EU, US, Japan).
** With the 2015 Annual Report, values back to 2011 were restated, as a result of a series of transactions during 2015.
This statistic was assembled from several editions of the Novartis annual report.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Novartis"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.